CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Marcus Institute

Marcus Institute is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The South Carolina Neurological Clinic, PA

The South Carolina Neurological Clinic, PA is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PCA Services

PCA Services Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kps Health Plans

Kps Health Plans is a Bremerton, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emblem Cannabis

We`re Emblem, a Health Canada-approved licensed producer of medical cannabis, including multiple dried flower strains and our highly-acclaimed, strain-specific cannabis oils.